Trial intelligence / Profile preview

Mifepristone for labor induction (MiLI)

NCT05097326Phase 3Completed

Sponsor
Stanford University
Start
Jun 2022
Primary completion
Apr 2023
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 3 trial of mifepristone in labor induction, sponsored by Stanford University. Started Jun 2022; status: completed.

02

Drugs

mifepristone
03

Conditions

labor induction

Beyond the preview

Go deeper on NCT05097326.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05097326.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call